The clinical evaluation of fever is a common yet challenging aspect of medical practice. This article aims to provide a comprehensive guide to effectively assess and manage fever in the clinical setting.
Fever represents a physiological response to infection, inflammation, or other internal disorders. It is typically identified when the body temperature exceeds 38.0°C (100.4°F). However, the clinical significance of fever extends beyond a mere symptom. It can serve as a valuable diagnostic clue, guiding the clinician towards the underlying cause.
The evaluation of fever should be systematic and patient-centered. The history should focus on the onset, duration, pattern, and associated symptoms. The physical examination should be thorough, emphasizing signs that may suggest specific etiologies. Laboratory investigations, including complete blood count, C-reactive protein, and cultures, may provide additional information. Imaging studies can also be useful in certain scenarios.
Management of fever depends on the underlying cause. In infectious causes, antimicrobial therapy is the mainstay of treatment. Inflammatory or autoimmune disorders may require immunosuppressive agents. Symptomatic management of fever with antipyretics should be considered, especially in patients with discomfort or significant comorbidities.
In certain populations, such as the elderly or immunocompromised, fever may be absent or subtle despite serious underlying conditions. Hence, a high index of suspicion is necessary. Similarly, fever of unknown origin (FUO) presents a diagnostic challenge, necessitating a broad differential and extensive workup.
Fever is a common clinical presentation with a broad differential. A comprehensive, systematic approach to evaluation can help clinicians identify the underlying cause and initiate appropriate management. By understanding the nuances of fever assessment, clinicians can enhance patient care and outcomes.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation